• 1. Organometallic reactions. Part VII. Further addition reactions of tributyltin methoxide and of bistributyltin oxide
  A. J. Bloodworth,Alwyn G. Davies,S. C. Vasishtha J. Chem. Soc. C 1967 1309
• 2. Organometallic reactions. Part VI. The addition of the Sn–O bond to the carbonyl group
  Alwyn G. Davies,W. R. Symes J. Chem. Soc. C 1967 1009
• 3. Syntheses of C17–C27 fragments of 20-deoxybryostatins for assembly using Julia and metathesis reactions
  Matthew Ball,Thomas Gregson,Hiroki Omori,Eric J. Thomas Org. Biomol. Chem. 2017 15 2740
• 4. Organometallic reactions. Part XVIII. The reactions of N-sulphinyltoluene-p-sulphonamide and of N-(2,2,2-trichloroethylidene)toluene-p-sulphonamide with some tributyltin–oxygen and –nitrogen compounds
  Alwyn G. Davies,John D. Kennedy J. Chem. Soc. C 1970 1570
• 5. Organometallic reactions. Part XIII. The reaction of trialkyltin alkoxides and of bistrialkyltin oxides with sulphur dioxide, sulphodi-imides, and sulphinylamines
  Alwyn G. Davies,John D. Kennedy J. Chem. Soc. C 1968 2630

Recent Advances in the Study of Methoxytributyltin (CAS: 1067-52-3): Applications and Implications in Chemical Biology and Medicine

Methoxytributyltin (CAS: 1067-52-3) is an organotin compound that has garnered significant attention in recent years due to its potential applications in chemical biology and medicine. Organotin compounds, including Methoxytributyltin, are known for their diverse biological activities, ranging from antimicrobial properties to potential anticancer effects. This research brief aims to summarize the latest findings related to Methoxytributyltin, focusing on its chemical properties, biological activities, and recent advancements in its applications.

Recent studies have highlighted the unique chemical structure of Methoxytributyltin, which contributes to its reactivity and interaction with biological systems. The compound's ability to form stable complexes with various biomolecules has been explored in the context of drug delivery systems and targeted therapies. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated that Methoxytributyltin could enhance the efficacy of certain chemotherapeutic agents by improving their bioavailability and reducing systemic toxicity.

In addition to its potential therapeutic applications, Methoxytributyltin has also been investigated for its role in environmental and toxicological studies. A recent report in Environmental Science & Technology examined the compound's persistence and bioaccumulation in aquatic ecosystems, raising concerns about its environmental impact. However, researchers are also exploring ways to mitigate these effects through the development of biodegradable derivatives and safer formulations.

One of the most promising areas of research involves the use of Methoxytributyltin in antimicrobial coatings and materials. A 2022 study published in Biomaterials Science showcased the compound's effectiveness against multidrug-resistant bacteria, suggesting its potential for use in medical devices and hospital surfaces. This application is particularly relevant in the context of the growing global threat of antibiotic resistance.

Despite these advancements, challenges remain in the widespread adoption of Methoxytributyltin-based technologies. Issues such as regulatory approval, scalability, and long-term safety need to be addressed. Ongoing research is focused on optimizing the synthesis of Methoxytributyltin to reduce production costs and improve yield, as highlighted in a recent ACS Sustainable Chemistry & Engineering publication.

In conclusion, Methoxytributyltin (CAS: 1067-52-3) represents a versatile compound with significant potential in chemical biology and medicine. Its unique properties and diverse applications make it a subject of ongoing research and development. Future studies will likely focus on addressing the current limitations and expanding its utility in both therapeutic and environmental contexts. This brief underscores the importance of continued investment in research to fully realize the potential of this promising compound.

• 358731-92-7(Tetrabutylstannane-d36)
• 82097-93-6(Copper, (tributylstannyl)-)
• 688-76-6(Propane,1,3-bis(2-chloroethoxy)-1-(2-methoxyethoxy)-)
• 59061-51-7(Stannane, trihexyl-)
• 50341-05-4(1-Butanol, 4-(tributylstannyl)-)
• 1067-97-6(Tributyl Tin Hydroxide)
• 1528-01-4(tributyl(methyl)stannane)
• 122829-02-1(Stannylium,dibutylmethyl- (9CI))
• 36643-28-4(Stannylium, tributyl-)
• 6180-99-0(Tri-n-butyltin deuteride)